Optimal dosing for Low-Dose Aspirin Chemoprophylaxis for Venous Thromboembolism Following Total Joint Arthroplasty - A Multicenter Prospective Randomized Control Trial
-
Enrollment
This study is currently enrolling. -
Research Area
Orthopedic Research -
Principal Investigator
-
Sponsor
University of Miami
Our primary objective is to evaluate the efficacy of two different regimens, 81mg aspirin daily vs 81mg aspirin BID, in providing prophylaxis against symptomatic thromboembolic events in patients undergoing total joint arthroplasty.
Enrollment Form
This study is currently enrolling.